Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong

  title={Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong},
  author={Mei Han Ho and Chi Wai Ho and Emmanuel Cheung and Pak Hei Chan and Jo Jo Siu Han Hai and Koon Ho Chan and Esther W Chan and Gilberto Ka-Kit Leung and Hung-Fat Tse and Chung Wah Siu},
  booktitle={PloS one},
BACKGROUND Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encourage long-term therapy. The objective was to describe long-term dabigatran therapy for stroke prevention in AF and to identify risk factors for discontinuation of therapy. METHODS AND RESULTS We… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 13 extracted citations


Publications referenced by this paper.
Showing 1-10 of 29 references

Efficacy and safety of novel anticoagulant dabigatran in clinical practice for Japanese patients with non-valvular atrial fibrillation

  • K Miyamoto, T Aiba, I Nakajima, Y Yamada, H Okamura
  • Journal of Arrhythmia
  • 2014
2 Excerpts

Management of dyspepsia symptoms on dabigatran during RELY-ABLE: Longterm follow-up study after RE-LY

  • W Nieuwlaat, J Healy, M Ezekowitz, P Reilly, S Formell
  • European Heart J 34(suppl
  • 2014
2 Excerpts

The Long - Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation ( RELY - ABLE ) Study

  • W Nieuwlaat, J Healy, M Ezekowitz, P Reilly, S Formell
  • Circulation
  • 2014

and bleeding in asians and non - asians with atrial fibrillation "

  • LB Yap, BI Rusani, D Umadevan, Z Muhammad, A Hussin
  • 2014

Similar Papers

Loading similar papers…